Clinical Trial Update: A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing multiple doses of SK-0403 to placebo and sitagliptin 100 mg in adults with type 2 diabetes not well controlled on metformin, evaluating …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SK-0403
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED